STOCK TITAN

uniQure (QURE) CEO auto-sells 12,378 shares to cover tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

uniQure N.V. CEO and Managing Director Matthew C. Kapusta reported an open-market sale of 12,378 ordinary shares of the company at a weighted average price of $23.86 per share. The shares were sold automatically upon the vesting of restricted share units solely to cover estimated withholding taxes, under pre-set sale instructions, and not as a discretionary trade. After this transaction, Kapusta directly held 639,076 ordinary shares of uniQure.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kapusta Matthew C

(Last) (First) (Middle)
C/O UNIQURE N.V.
PAASHEUVELWEG 25A

(Street)
AMSTERDAM P7 11058BP

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO, Managing Director
3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/25/2026 S(1) 12,378(1) D $23.86(2) 639,076 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.64 to $24.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Christian Klemt, Attorney-in-Fact 02/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did uniQure (QURE) report for Matthew C. Kapusta?

uniQure reported that CEO Matthew C. Kapusta sold 12,378 ordinary shares. The sale was tied to vesting of restricted share units and was executed automatically under preset instructions to cover estimated withholding taxes, rather than being a discretionary trade.

At what price were Matthew C. Kapusta’s uniQure (QURE) shares sold?

The reported weighted average sale price was $23.86 per share. Footnotes state the shares were sold in multiple transactions with prices ranging from $23.64 to $24.06, reflecting execution across a narrow trading band on the transaction date.

Why did the uniQure (QURE) CEO sell 12,378 shares in this Form 4 filing?

The shares were sold solely to cover estimated withholding taxes upon vesting of restricted share units. The sale followed automatic instructions in the Restricted Share Unit Agreement, meaning it was not a discretionary trade by the reporting person in the open market.

How many uniQure (QURE) shares does Matthew C. Kapusta hold after the reported sale?

After the transaction, Matthew C. Kapusta directly owned 639,076 ordinary shares. This figure reflects his direct holdings immediately following the 12,378-share sale that was executed to satisfy estimated tax withholding obligations tied to restricted share unit vesting.

Was the uniQure (QURE) CEO’s share sale a routine tax withholding transaction?

Yes. Footnotes clarify the shares were sold upon restricted share unit vesting solely to cover estimated withholding taxes. The sale followed automatic instructions in the award agreement, distinguishing it from a voluntary, discretionary decision to reduce his investment position.

What price range applied to the uniQure (QURE) CEO’s Form 4 share sales?

The filing states that individual sales occurred between $23.64 and $24.06 per share. The reported $23.86 figure is a weighted average, and detailed breakdowns of shares sold at each price are available on request from the issuer or the reporting person.
Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

1.07B
58.51M
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM